Relation of exploratory behavior of rats in elevated plus-maze to brain receptor binding properties and serum growth hormone levels

European Neuropsychopharmacology

Volumn 7, Issue 4, 1997, Pages 289-294

  Kõks, Sulev ^a   Vasar, Eero ^a   Soosaar, Andres ^a   Lang, Aavo ^a   Volke, Vallo ^a   Võikar, Vootele ^a   Bourin, Michel ^b   T Männistö, Pekka ^c  

^a UNIVERSITY OF TARTU   (Estonia)

^b UNIVERSITÉ DE NANTES   (France)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Blood hormone levels; Elevated plus maze; Exploratory activity; Neurotransmitter receptors; Selection of rats

Indexed keywords

BENZODIAZEPINE RECEPTOR; BRAIN RECEPTOR; CHOLECYSTOKININ; CHOLECYSTOKININ RECEPTOR; GROWTH HORMONE; NEUROTRANSMITTER RECEPTOR; SEROTONIN;

ADENOHYPOPHYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BINDING SITE; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; FRONTAL CORTEX; GROWTH HORMONE BLOOD LEVEL; HIPPOCAMPUS; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN; EXPLORATORY BEHAVIOR; FRONTAL LOBE; GROWTH HORMONE; HIPPOCAMPUS; MALE; NEOSTRIATUM; PITUITARY HORMONES; RATS; RATS, WISTAR; RECEPTORS, CHOLECYSTOKININ; RECEPTORS, DOPAMINE D2; RECEPTORS, GABA-A; RECEPTORS, SEROTONIN;

EID: 0343376076     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(97)00034-5     Document Type: Article

References (36)

1. Andrews N., File S.E. Increased 5-HT release mediates the anxiogenic response during benzodiazepine withdrawal: a review of supporting neurochemical and behavioral evidence. Psychopharmacology. 112:1993;21-25.
2. Barrett J.E., Vanover K.E. 5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions. Psychopharmacology. 112:1993;1-12.
3. Belzung C., Pineau N., Beuzen A., Misslin R. PD135158, a CCK-B antagonist, reduces 'state', but not 'trait' anxiety in mice. Pharmacol. Biochem. Behav. 49:1994;433-436.
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
5. Bradwejn J., de Montigny C. Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurons. Nature. 312:1984;363-364.
6. 3H]-diazepam binding. Proc. Natl. Acad. Sci. USA. 74:1977;3805-3809.
7. Charney D.S., Woods S.W., Goodman W.K., Heninger G.R. Serotonin function in anxiety. II. Effects of serotonin agonist mCPP in panic disorder patients and healthy subjects. Psychopharmacology. 92:1987;14-24.
8. Crawley J.N., Corwin R.L. Biological actions of cholecystokinin. Peptides. 15:1994;731-755.
9. File S.E., Zangrossi J.R., Andrews N. Social interaction and elevated plus-maze tests: changes in release and uptake of 5-HT and GABA. Neuropharmacology. 32:1993;217-221.
10. Glavin G.B. Vulnerability to stress ulcerogenesis in rats differing in anxiety: a dopaminergic correlate. J. Physiol. Paris. 87:1993;239-243.
11. Handley S.L., Mithani S. Effects of alpha-adrenoreceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behavior. Naunyn-Schmiedeberg's Arch. Pharmacol. 327:1984;1-5.
12. Handley S., McBlane J.W. 5HT drugs in animal models of anxiety. Psychopharmacology. 112:1993;13-20.
13. Handley S. Future prospects for the pharmacological treatment of anxiety. CNS Drugs. 2:1994;397-414.
14. Harro J., Kiivet R.A., Lang A., Vasar E. Rats with anxious or non-anxious type of exploratory behavior differ in their brain CCK-8 and benzodiazepine receptor characteristics. Behav. Brain Res. 39:1990;63-71.
15. Harro J., Vasar E., Bradwejn J. Cholecystokinin in animal and human research of anxiety. Trends Pharmacol. Sci. 14:1993;244-249.
16. B receptors in the rat brain. Mol. Cell. Neurosci. 4:1993;143-154.
17. Iversen S.D. 5-HT and anxiety. Neuropharmacology. 23:1984;1553-1560.
18. B-selective agonist BC264 on extracellular dopamine content in the anterior and posterior nucleus accumbens: a microdialysis study in freely moving rats. Brain Res. 628:1993;254-262.
19. Ladurelle N., Roques B.P., Dauge V. The transfer of rats from a familiar to a novel environment prolongs the increase of extracellular dopamine efflux induced by CCK8 in the posterior nucleus accumbens. J. Neurosci. 15:1995;3118-3127.
20. Lang A., Vasar E., Soosaar A., Harro J. The involvement of sigma and phencyclidine receptors in the action of antipsychotic drugs. Pharmacol. Toxicol. 71:1992;132-138.
21. Lang A., Harro J., Soosaar A., Kõks S., Volke V., Oreland L., Bourin M., Vasar E., Bradwejn J., Männistö P.T. Role of N-methyl-D-aspartic acid and cholecystokinin receptors in apomorphine-induced aggressive behavior in rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 351:1995;363-370.
22. Leatherbarrow, R.J., 1987. Enzfitter, a non-linear regression data analysis program for the IBM PC. Elsevier, Amsterdam.
23. Marsden, C.A., Bickerdike, M., Cadogan, A.K., Wright, I., Rex, A. and Fink, H., 1993. Serotoninergic mechanisms and animal models of anxiety. In: Hamon, M.; Ollat, H.; Thiebot, M. H., (Eds.), Anxiety: Neurobiology, Clinic and Therapeutic Perspectives. John Libbey Eurotext Ltd., Montrouge, pp. 75-82.
24. B receptors in behavioral and hormonal studies in rats housed in social groups. Naunyn-Schmiedeberg's Arch. Pharmacol. 349:1994;478-484.
25. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods. 14:1985;149-167.
26. Peuranen, E., Lang, A., Harro, J., Vasar, E. and Männistö, P.T., 1994. Effect of CCK-agonists and antagonists on hypophyseal hormone secretion in single-housed and group-housed male rats. In: Seredenin, S.; Longo, V.G.; Gavirachi, G., (Eds.), Biological Basis of Individual Sensitivity to Psychotropic Drugs (Proc. 2nd Intern. Golden Ring Confer.) Graffham Press, Edinburgh, pp. 63-72.
27. Peuranen E., Vasar E., Kõks S., Volke V., Lang A., Rauhala P., Männistö P.T. Further studies on the role of cholecystokinin-A and B receptors in secretion of anterior pituitary hormones in male rats. Neuropeptides. 28:1995;1-11.
28. Pratt J.A. The neuroanatomical basis of anxiety. Pharmacol. Ther. 55:1992;149-181.
29. Pratt J.A., Brett R.R. The benzodiazepine inverse agonist FG 7142 induces cholecystokinin gene expression in rat brain. Neurosci. Lett. 184:1995;197-200.
30. Rägo L., Kiivet R.A., Harro J., Pôld M. Behavioral differences in an elevated plus-maze: correlation between anxiety and decreased number of GABA and benzodiazepine receptors in mouse cerebral cortex. Naunyn-Schmiedberg's Arch. Pharmacol. 337:1988;675-678.
31. Rägo L., Adojaan A., Harro J., Kiivet R.A. Correlation between exploratory activity in an elevated plus-maze and number of central and peripheral benzodiazepine binding sites. Naunyn-Schmiedberg's Arch. Pharmacol. 343:1991;301-306.
32. Rex A., Marsden C.A., Fink H. Effect of diazepam on cortical 5-HT release and behavior in the guinea-pig exposure to the elevated plus-maze. Psychopharmacology. 110:1993;233-236.
33. Rex A., Fink H., Marsden C.A. Effects of BOC-CCK-4 and L-365,260 on cortical 5-HT release in guinea-pigs on exposure to the elevated plus-maze. Neuropharmacology. 33:1994;559-565.
34. Tuomisto J., Männistö P.T. Neurotransmitter regulation of anterior pituitary hormones. Pharmacol. Rev. 37:1985;249-332.
35. Vaccarino F. Nucleus accumbens dopamine-CCK interactions in psychostimulant reward and related behaviors. Neurosci. Biobehav. Rev. 18:1994;207-214.
36. Vasar E., Peuranen E., Ööpik T., Harro J., Männistö P.T. Ondansetron, an antagonist of 5-HT3 receptors, antagonizes the anti-exploratory effect of caerulein, an agonist of CCK receptors, in the elevated plus-maze. Psychopharmacology. 110:1993;213-218.